| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Departments of Medical Biophysics and Immunology, Ontario Cancer Institute; and
Amgen Institute, Toronto, Ontario, Canada
CTLA-4 has been proposed to negatively regulate immune responses, and mice deficient for CTLA-4 expression succumb to a lymphoproliferative disorder within a few weeks after birth. This study assessed the responsiveness of CTLA-4-deficient T cells expressing a class I-restricted TCR specific for lymphocytic choriomeningitis virus (LCMV). The kinetics of T cell proliferation were studied in vitro after stimulation of T cells with full and partial T cell agonists. No gross abnormalities in CTLA-4-deficient T cells could be detected. Using adoptive transfer experiments, T cell responses were also measured in vivo after infection with LCMV. Low dose infection with LCMV leads to strong expansion of specific T cells followed by a reduction in T cells that parallels the elimination of Ag. The kinetics of T cell expansion and elimination after low dose LCMV infection were not affected by the absence of CTLA-4. High dose infection of mice with LCMV leads to a transient expansion of T cells followed by T cell exhaustion, where all specific T cells are eliminated. T cell exhaustion also occurred in the absence of CTLA-4. Thus, surprisingly, the absence of CTLA-4 did not interfere with T cell activation, down-regulation of ongoing T cell responses after the elimination of Ag, or the exhaustion of T cell responses in the presence of excessive amounts of Ag.
This article has been cited by other articles:
|
|
 |
|
  V. A. Love, N. Grabie, P. Duramad, G. Stavrakis, A. Sharpe, and A. Lichtman CTLA-4 Ablation and Interleukin-12 Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes Circ. Res., August 3, 2007; 101(3): 248 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mostbock, M. Catalfamo, Y. Tagaya, J. Schlom, and H. Sabzevari Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis Blood, March 15, 2007; 109(6): 2488 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity J. Virol., January 1, 2006; 80(1): 270 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Boudewijns, A. Jeurissen, M. Wuyts, L. Moens, L. Boon, J. J. Van Neerven, A. Kasran, L. Overbergh, C. Lenaerts, M. Waer, et al. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides J. Leukoc. Biol., November 1, 2005; 78(5): 1060 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Iwai, S. Terawaki, and T. Honjo PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells Int. Immunol., February 1, 2005; 17(2): 133 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Inobe and R. H. Schwartz CTLA-4 Engagement Acts as a Brake on CD4+ T Cell Proliferation and Cytokine Production but Is Not Required for Tuning T Cell Reactivity in Adaptive Tolerance J. Immunol., December 15, 2004; 173(12): 7239 - 7248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Workman, L. S. Cauley, I.-J. Kim, M. A. Blackman, D. L. Woodland, and D. A. A. Vignali Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo J. Immunol., May 1, 2004; 172(9): 5450 - 5455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size J. Immunol., October 1, 2002; 169(7): 3744 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-F. Bai, J. Liu, K. F. May Jr, Y. Guo, P. Zheng, and Y. Liu B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo Blood, April 15, 2002; 99(8): 2880 - 2889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ferrari-Lacraz, X. X. Zheng, Y. S. Kim, Y. Li, W. Maslinski, X. C. Li, and T. B. Strom An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection J. Immunol., September 15, 2001; 167(6): 3478 - 3485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Gajewski, F. Fallarino, P. E. Fields, F. Rivas, and M.-L. Alegre Absence of CTLA-4 Lowers the Activation Threshold of Primed CD8+ TCR-Transgenic T Cells: Lack of Correlation with Src Homology Domain 2-Containing Protein Tyrosine Phosphatase J. Immunol., March 15, 2001; 166(6): 3900 - 3907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Chai, S. Vendetti, E. Amofah, J. Dyson, and R. Lechler CD152 Ligation by CD80 on T Cells Is Required for the Induction of Unresponsiveness by Costimulation-Deficient Antigen Presentation J. Immunol., September 15, 2000; 165(6): 3037 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Dalton, L. Haynes, C.-Q. Chu, S. L. Swain, and S. Wittmer Interferon {gamma} Eliminates Responding Cd4 T Cells during Mycobacterial Infection by Inducing Apoptosis of Activated Cd4 T Cells J. Exp. Med., July 3, 2000; 192(1): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sakurai, J. Ohata, K. Saito, H. Miyajima, T. Hirano, T. Kohsaka, S. Enomoto, K. Okumura, and M. Azuma Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells J. Immunol., January 15, 2000; 164(2): 664 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Slifka and J. L. Whitton Activated and Memory CD8+ T Cells Can Be Distinguished by Their Cytokine Profiles and Phenotypic Markers J. Immunol., January 1, 2000; 164(1): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bachmann, G. Kohler, B. Ecabert, T. W. Mak, and M. Kopf Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous J. Immunol., August 1, 1999; 163(3): 1128 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Chambers, M. S. Kuhns, and J. P. Allison Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+ T cell responses PNAS, July 20, 1999; 96(15): 8603 - 8608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khattri, J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone Lymphoproliferative Disorder in CTLA-4 Knockout Mice Is Characterized by CD28-Regulated Activation of Th2 Responses J. Immunol., May 15, 1999; 162(10): 5784 - 5791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Brunner, C. A. Chambers, F. K.-M. Chan, J. Hanke, A. Winoto, and J. P. Allison CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation J. Immunol., May 15, 1999; 162(10): 5813 - 5820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.A. CHAMBERS and J.P. ALLISON CTLA-4 -- The Costimulatory Molecule That Doesn't: Regulation of T-cell Responses by Inhibition Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 303 - 312. [Abstract] [PDF]
|
|
|
|
 |
|
 L. V. Parijs and A. K. Abbas Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off Science, April 10, 1998; 280(5361): 243 - 248. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Sullivan, J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, C. A. Chambers, and J. P. Allison Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation PNAS, February 27, 2001; 98(5): 2587 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Luhder, C. Chambers, J. P. Allison, C. Benoist, and D. Mathis Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells PNAS, October 24, 2000; 97(22): 12204 - 12209. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
